2007 National Healthcare Disparities Report: Data Tables Appendix--Table 102d

You Are Here: AHRQ Home > Quality Assessment > Measuring Healthcare Quality > National Healthcare Quality & Disparities Reports, 2007 > Disparities Report, Data Tables Appendix

Table 102d
Persons age 18 and over who needed treatment for any illicit drug use and who received such treatment at a specialty facility in the past year,^a by education,^b United States, 2005

Population group		Total		Less than high school		High school graduate		At least some college
Population group		Percent	SE	Percent	SE	Percent	SE	Percent	SE
Total		18.1	1.5	22.2	3.2	19.2	2.5	14.1	2.1
Age	18-44	17.5	1.5	21.5	3.1	20.0	2.8	12.2	1.8
	45-64	*	*	*	*	*	*	*	*
	65 and over	*	*	*	*	*	*	*	*
Gender	Male	16.9	1.9	21.5	4.0	16.4	2.6	13.7	3.0
Gender	Female	20.1	2.4	23.6	5.1	24.3	5.0	14.7	2.6
Race	White only	16.5	1.5	17.2	2.8	19.6	2.6	13.3	2.3
	Black only	26.7	4.3	*	*	*	*	*	*
	Asian only	*	*	*	*	*	*	*	*
	NHOPI only	*	*	*	*	*	*	*	*
	AI/AN only	*	*	*	*	*	*	*	*
	Multiple races	*	*	*	*	*	*	*	*
Ethnicity	Hispanic	*	*	*	*	*	*	*	*
Ethnicity	Non-Hispanic	17.5	1.5	22.3	3.5	18.2	2.3	13.7	2.0
Residence location	MSA	17.5	1.7	20.5	3.5	19.9	2.9	13.3	2.2
Residence location	Non-MSA	21.7	3.3	*	*	15.4	3.5	*	*

^a Received any illicit drug treatment at a specialty facility refers to treatment received at a hospital (inpatient), a rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop drug use, or for medical problems associated with drug use. Respondents were classified as needing treatment for an illicit drug problem if they met at least one of three criteria during the past year: 1), dependent on any illicit drug; 2), abuse of any illicit drug; or 3), received treatment for an illicit drug problem at a specialty facility, i.e., drug and alcohol rehabilitation facilities (inpatient or outpatient), hospitals (inpatient only), and mental health centers. Illicit drugs include marijuana/hashish, cocaine (including crack), inhalants, hallucinogens, heroin, and prescription-type psychotherapeutic nonmedical use.

^b All estimates are for persons age 18 and over only.

^* Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Key: AI/AN: American Indian or Alaska Native; NHOPI: Native Hawaiian or Other Pacific Islander; MSA: metropolitan statistical area; SE: standard error.

Source: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, National Survey on Drug Use and Health.